Estimation of Amoxicillin Trihydrate and Ciprofloxacin Hydrochloride from Different Marketed Brands of Tablets by UV Spectroscopy

Authors

  • R. Narayana Charyulu Professor, Vice Principal & Head NGSM Institute of Pharmaceutical Sciences Paneer, Derlakatte, Mangalore 574 160, Karnataka
  • Sandeep D.S. Department of Pharmaceutics, NGSM Institute of Pharmaceutical sciences, Paneer, Deralakatte, Mangalore, Karnataka, India

Abstract

In the present work percentage of drug content of Amoxicillin trihyadrate and Ciprofloxacin from the marketed brands of tablets was estimated by UV spectrophotometer. Three different brands of tablets each of Amoxicillin (Mox, Novamox and Erox) and Ciprofloxacin (Cifran, Ciplox and Microflox)  are purchased from the retail drug store and all the brands of tablets of Amoxicillin and Ciprofloxacin drug content was estimated from the standard calibration curve of both the drugs in phosphate buffer pH 1.2. Amoxicillin has lambda max of 246.5 nm with beer’s range of 10–40 µg/ml and ciprofloxacin has lambda max of 276 nm with beer’s range of 5–30 µg/ml. Percentage drug content of all the three brands of tablets was estimated from the standard calibration curve of respective drugs. From this work it was concluded that all the brands of tablets of amoxicillin and ciprofloxacin were found to within the standard limits of drug content specifications.

 

Keywords: UV spectroscopy, Amoxicillin trihydrate and Ciprofloxacin

Cite this Article

Sandeep DS, Narayana CR. Estimation of Amoxicillin Trihydrate and Ciprofloxacin Hydrochloride from Different Marketed Brands of Tablets by UV Spectroscopy. Research & Reviews: A Journal of Drug Design & Discovery. 2016; 3(1): 31–34p.

Downloads

Published

2019-03-19

Issue

Vol. 3 No. 1 (2016)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.